Edinburgh Travel Massive

BENCHMARK GENETICS AT THE 4TH ICISB CONFERENCE, HELD IN EDINBURGH

Benchmark Genetics were honoured to sponsor the event held in the Royal College of Surgeons in Edinburgh which has a long history of scientific understanding of evolution, physiology and genetics.

From 17 to 20 November, the 4thInternational Conference of Comparative Salmonid Biology (ICISB) was held in the city of Edinburgh. The ICISB conference, created and organized by the International Cooperation to sequence Atlantic salmon Genome as a forum to share the knowledge achieved from sequencing the Atlantic salmon genome, brought together scientists from industry and research groups working on genetics, ecology, evolution and physiology to share advances in understanding of the biology of salmon species.

"It was a pleasure to help support this unique conference in Edinburgh to promote communication and collaboration between world-class scientists from different specialities to find new ways of using sequence information and genomics to improve our understanding of salmon genetics and evolution." Alan Tinch, Technical Services Director of Benchmark Genetics

During the meeting two of Benchmark Genetics senior geneticists shared great results at the conference.

Dr. Havard Bakke, Director of Business Development at Benchmark Genetics presented on “Genome-wide association study of piscine myocarditis virus (PMCV) resistance in Atlantic salmon”. Benchmark Genetics have discovered and are using markers for a QTL (assumed to be a major gene) conferring resistance to the PMCV virus which causes Cardiomyopathy Syndrome (CMS) in Atlantic salmon in Norway and Scotland.

Dr. Jean Paul Lhorente, Technical Director Genetics and R&D at Benchmark Genetics Chile presented on “Genetic resistance to Bacterial Kidney Disease-BKD: Application of Genomic selection in an Atlantic Salmon Breeding program”. This study investigated the inheritance of resistance to Bacterial Kidney Disease showing that resistance is determined by many genes. The authors described how Genomic Selection (ie using high density genotyping of many thousands of genetic markers can be used to predict resistance to BKD of individual salmon) will be used to improve the robustness of salmon in Chile.

Both studies show investment and commitment from the Benchmark Genetics teams in Norway, Iceland and Chile to use emerging technology to improve health and welfare of salmon worldwide.

Img 0917

Dr. Havard Bakke, Director of Commercial Development at Benchmark Genetics Norway presented on "Genome-wide association study of piscine myocarditis virus (PMCV) resistance in Atlantic salmon".

Img 0923

Dr. Jean Paul Lhorente, Benchmark Genetics Chile presented on "Genetic resistance to Bacterial Kidney Disease-BKD: Application of Genomic selection in an Atlantic Salmon Breeding program".

main.css loaded.